author-photo

Parnia Geransar

Novartis

5

Papers

96

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Treatment adherence with vildagliptin compared to sulphonylurea as add-on to metformin in Muslim patients with type 2 diabetes mellitus fasting during Ramadan

2013 Current Medical Research and Opinion
Show All
- Source
- Cite
- Save
Citations (17)
Vildagliptin more effectively achieves a composite endpoint of HbA1c < 7.0% without hypoglycaemia and weight gain compared with glimepiride after 2 years of treatment

2013 Diabetes Research and Clinical Practice
Show All
- Source
- Cite
- Save
Citations (19)
Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study

2011 Current Medical Research and Opinion
Show All
- Source
- Cite
- Save
Citations (59)
Vildagliptin as an add-on agent in type 2 diabetes in a multi-ethnic UK clinic: a single-centre audit

2011 The British Journal of Diabetes & Vascular Disease
Show All
- Source
- Cite
- Save
Citations (0)
A UK retrospective observational survey of vildagliptin as add-on antidiabetes therapy in elderly patients

2011 The British Journal of Diabetes & Vascular Disease
Show All
- Source
- Cite
- Save
Citations (1)